Milan, December 16th 2024 – Life Science Newswire – BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
